Two Top Stories of NYSE: VeriFone Systems, Inc. (NYSE:PAY), Editas Medicine Inc. (NASDAQ:EDIT)

VeriFone Systems, Inc. (NYSE:PAY)

The shares of VeriFone Systems, Inc. (NYSE:PAY) started off the last trading session with the price of $17.82 while closing the day with the price of $17.82. The shares of VeriFone Systems, Inc. (NYSE:PAY) Rise 0.17% with the Gain of 0 points.

The shares of VeriFone Systems, Inc. (NYSE:PAY) traded with the day volume of 1.91 Million shares whereas its average trading volume is 1.29 Million.

While analyzing the past performance of the stock we can see that the shares of VeriFone Systems, Inc. (NYSE:PAY) Loss -3.52% in the last week while rising 2.77% in the last month. Past quarter performance shows the green light with 0.34%. The semi-annual and annual performance shows -13.83% and -6.6% respectively.

Some critical values of the shares of VeriFone Systems, Inc. (NYSE:PAY) to be discussed here are: the beta which shows the value at 1.75 while Average True Range of VeriFone Systems, Inc. (NYSE:PAY) demonstrate the value at 0.48. The weekly and monthly volatility of the shares of VeriFone Systems, Inc. (NYSE:PAY) are indicated at 2.28% and 2.55%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 53.

While studying the financial position of the shares of VeriFone Systems, Inc. (NYSE:PAY), we can see that the Market capitalization of the company is at 1.96 Billion. The shares outstanding for the company is 110.21 Million and the shares float stands at 109.63 Million. The income of the company stand at -103100000 while the sales stand at 1.85 Billion.

Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at -0.92, Price to Earnings or P/E is at 0, Price to Sales P/S show the value of 1.06, the Return on Asset ROA stood at 0 and the Return on Equity ROE depicted at 0 while Return on Investment ROI is at -0.091.


Editas Medicine Inc. (NASDAQ:EDIT)

Editas Medicine Inc. (NASDAQ:EDIT) started its previous trading session at $39.81 and closed at $38.02 showing a Fell of -3.36 Percent.

The Company traded with an average Volume of 1.69 Million whereas, its Day Volume stood at 1.91 Million.

Looking at the performance of the stock, Editas Medicine Inc. (NASDAQ:EDIT) Loss -13.75% in the last week in its shares price and 9.92% in the last month. Quarterly performance shows a green of 56.01 Percent while Semi-Annual and Annual performances shows a 80.19 and 52.63 percent respectively.

Beta for Editas Medicine Inc. (NASDAQ:EDIT) stands at 0 while the ATR (average true range) is at 2.97. The Stock’s Weekly and Monthly Volatility is 8.65% and 7.47% respectively showing a RSI value of 51.31.

While studying the financial position of the shares of Editas Medicine Inc. (NASDAQ:EDIT), we can see that the Market capitalization of the company is at 1.84 Billion. The shares outstanding for the company is 48.51 Million and the shares float stands at 40.05 Million.

The Company generated an income of -120300000 and the sales of 13.7 Million in the Trailing Twelve Months period.

While analyzing the stock from technical aspects, Diluted Earnings per share stands at $-2.99 a share. P/E (price to earnings) and P/S (price to sales) values are 0 and 134.62 respectively.

The Return on Assets stands at -0.326, ROE shows a value of -0.619 and ROI for Editas Medicine Inc. (NASDAQ:EDIT) is -0.482 as of Trailing Twelve Months period.

View all contributions by

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

    Leave a Comment